Indonesia Vaccine Support

Australia has commited $101.9 million for COVID-19 vaccine access during 2020-23 in Indonesia.

Doses:
  • 10 million vaccine doses committed from Australia’s supply
  • 5.6 million vaccine doses delivered so far
  • 10 million COVID-19 vaccine doses to be procured through Australia’s agreement with UNICEF

Supporting National Vaccine Rollout
  • Risk Communications
  • Registration data and monitoring
  • Supply chain preparedness
  • Human resources

Providing Technical Expertise
  • Strengthening systems to ensure vaccine safety
  • Using evidence to build quality immunisation

 

Our Impact So Far

  • Through WHO, we funded rapid technical assessments in 11 villages to assist targeting vaccines for priority groups under Bali's reopening agenda and supported the increase of vaccination teams for vaccine roll-out.
  • Funded technical support from UNICEF to the Ministry of Health for the procurement of 17 ultracold chain units via COVAX -  critical for the continued roll-out out of Pfizer doses.
  • Through UNICEF, we supported Indonesia develop a publicly accessible vaccine monitoring dashboard that details vaccine distribution and coverage at the national, provincial and district level.
  • Through UNICEF, we supported the Ministry of Health to undertake an ‘effective vaccine management’ assessment of private sector hubs to improve vaccine logistics. 
  • Our Australia-Indonesia Health Security Partnership paired with CSIRO experts to assist Ministry of Health to develop a prototype platform for advanced Whole Genome Sequencing analysis.

Download a factsheet: Australia's Vaccine Support to Indonesia

1.2 Million October 2021 Vaccine delivery Indonesia

More than 2 million COVID-19 vaccine doses shared with Indonesia

Australia has now delivered 2.2 million vaccine doses of our 2.5 million dose commitment for 2021 to Indonesia.
The Eijkman Institute

Indonesia and Australia partner for enhanced COVID-19 response

Australia is working together with Indonesia to respond to the challenges posed by the pandemic and to assist our friend and partner in its national vaccine roll out.